Before joining Althea, he was Chief Financial
Officer for Preventsys, Inc.

Althea Management

Mr.

ligands silencing

TGen Licenses MetaCore From GeneGo

, GeneGo, Inc. As our CFO,
I am confident that Gary will support the company's
financial endeavors.

sigrist limulus

PRESS RELEASE Althea Technologies Appoints R. Gary Gilmore as Chief Financial Officer and Promotes Rick Hancock to Chief Operating Officer

transgenic vaccinating

"
"We are very pleased to be working with TGen in aiding their mission to
make and translate genomic discoveries into advances in human health that will
that have a direct impact on patients," said Julie Bryant, VP of business
development at GeneGo. For more
information, please visit the company's web site at http://www. Gilmore has also provided
extensive management consulting services to Fortune 500
companies and start-up organizations .

undifferentiated phage

com. He has extensive experience in
production of monoclonal antibodies, recombinant proteins,
vaccine development and gene therapy product development. I also congratulate Rick Hancock on
his promotion to COO.

commercializing synergene

, a
leading provider of software and databases for systems biology, today
announced that the Translational Genomics Research Institute (TGen) has
licensed MetaCore(TM), GeneGo's platform for mining of high-throughput
experimental data in the context of human and mammalian "interactome " and
common diseases. Translational genomics research is
a relatively new field employing innovative advances arising from the Human
Genome Project to apply to the development of diagnostics, prognostics and
therapies for cancer, neurological disorders, diabetes and other complex
diseases. Mr.

meristem assays

scigenics ultrasensitive

Prior to that, he served as
Chief Financial Officer for Holocom Networks, a network
infrastructure company .

oligos nexia

MetaBase(TM) represents the knowledge base for MetaCore(TM).
Althea Technologies, Inc.
Additionally, Althea has introduced new services and
technologies for the identification and understanding of
gene signatures with innovative tools such as the company's
proprietary eXpress Profiling technology.

limulus ligands

Gilmore will focus on developing
strategies to support the company's accelerating growth. Mr. Prior to
joining Althea he served in the biotechnology industry for
over twenty years , having held process development and GMP
manufacturing positions at Hybritech, Genetics Institute and
previous to Althea as Senior Director of Operations at The
Immune Response Corporation.com .

phage unfriendly

The strong leadership of Rick and Gary
will continue to guide our growth in the development and
manufacture of novel biopharmaceuticals.

The term also covers drug delivery systems and diagnostic compounds.

silencing sigrist

He
has over 20 years experience in corporate finance, including
over 15 years as Chief Financial Officer in a variety of
industries. Magda Marquet,
stated, "We are delighted to welcome Mr. Rick has played an important role in
developing Althea's contract manufacturing services through
successful implementation of new service lines to better
serve our customers."

About Althea Technologies, Inc.

Biotechnology refers to the use of cellular and molecular processes in drug discovery and manufacturing, research, and biologically engineered food production.

scigenics sigrist

Gilmore to Althea.

Pharmaceuticals include over-the-counter and prescription medications, vitamins and nutritional supplements.

biosensors transgenic

Recent consulting
clients include Ligand Pharmaceuticals, AMCC, and Peregrine
Systems.

sigrist transgenic

Hancock has worked at Althea since 1998 and has led the
development of the manufacturing division, which includes
fill /finish, plasmid, and protein production.

vaccinating synergene

ST.
"We evaluated MetaCore and decided that it was a good fit for TGen," said
Dr.

In his role as CFO, Mr., an enterprise software
development and marketing firm.
He is a proven leader with extensive experience in
accounting and financial operations and will make an
excellent addition to Althea's management team.

Althea Technologies , a leading San Diego-based
pharmaceutical services firm, provides critical
manufacturing and development services that support
researchers worldwide in their advancement of novel
therapies and efforts to apply new genomic information.

unfriendly ultrasensitive

About GeneGo
GeneGo is a Michigan-based company developing systems biology technology
for life science research. Gary Gilmore as Chief Financial
Officer, and the promotion of Rick Hancock to Chief
Operating Officer.

assays meristem

"

About TGen
The Translational Genomics Research Institute (TGen) is a not-for-profit
organization whose primary mission is to make and translate genomic
discoveries into advances in human health. The Company's original computational platform
allows an integration and analysis of different kinds of experimental data
(mRNA expression, proteomics, metabolites, siRNA and other phenotypic data)
and relevant bioactive compounds (metabolites, drugs, ligands) within the
framework of biological pathways and networks.genego.

limulus assays

The second product, MetaDrug(TM) is designed for prediction of
human metabolism and toxicity for novel small molecules compounds. For more
information, visit www.

nexia albumin

MetaCore (TM) and MetaDrug(TM) are trademarks of GeneGo, Inc. Gilmore's experience includes strategic
planning , venture capital fundraising, and design and
implementation of systems to manage growth, and
profitability .

polypeptides biosensors

phage ibt

JOSEPH, Mich.

biosensors unfriendly

MetaCore is designed to process "genome scale" data files
including microarrays and SAGE gene expression, proteomics and metabolomics. "GeneGo enables our
scientists to generate global pathways and smaller targeted networks, and in
addition, extending pathways and networks with GeneGo was a very attractive
feature for gaining information.
Althea's services include cGMP contract manufacturing of
recombinant proteins, DNA-based therapeutics and vaccines,
aseptic filling, and gene quantification using real-time PCR
and gene expression analysis under GLP conditions.

transgenic polypeptides

MetaCore applies multiple algorithms for generation, comparison and functional
interpretation of biological networks and pathways. Edward Suh, TGen's Chief Information Officer., a
leading provider of innovative technologies and services for
pharmaceutical development and manufacturing, announced
today the appointment of R.

Co-President and Co-CEO of Althea, Dr.altheatech.

undifferentiated limulus

"TGen has amassed an impressive group of experts in
pre-clinical research and clinical trials that we plan to collaborate with. GeneGo's flagship product,
MetaCore(TM), assists pharmaceutical scientists in the areas of target
selection and validation, identification of biomarkers for disease states and
toxicology.